Literature DB >> 16423442

Induction and expression mechanisms of postsynaptic NMDA receptor-independent homosynaptic long-term depression.

Roger Anwyl1.   

Abstract

The induction of long-term depression (LTD) can be divided into two main forms, one dependent upon activation of postsynaptic NMDAR, and another independent of postsynaptic NMDAR. Non-postsynaptic NMDAR-LTD (non-NMDAR-LTD) occurs in many regions of the brain, and encompasses a wide variety of induction and expression mechanisms. In this article, the induction and expression mechanisms of such LTD in over 10 brain regions are described, with a number of common mechanisms compared across a large range of types of LTD. The article describes the involvement of different presynaptic or postsynaptic receptors in the induction of non-NMDAR-LTD, especially metabotropic glutamate receptors, cannabinoid receptors and dopamine receptors. An increase in presynaptic or postsynaptic intracellular Ca concentration is a key event in induction, commonly followed by activation of certain kinases, especially PKC, p38 MAPK and ERK. Expression mechanisms are either presynaptic via a reduction in release probability, or postsynaptic involving a decrease in AMPAR via phosphorylation of a glutamate receptor subunit, especially GluR2, followed by clathrin-mediated endocytosis. Retrograde signalling from postsynaptic to presynaptic occurs when induction is postsynaptic and expression is presynaptic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423442     DOI: 10.1016/j.pneurobio.2005.12.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  28 in total

1.  Co-induction of LTP and LTD and its regulation by protein kinases and phosphatases.

Authors:  Kathryn B Grey; Brian D Burrell
Journal:  J Neurophysiol       Date:  2010-03-24       Impact factor: 2.714

Review 2.  NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders.

Authors:  Charles F Zorumski; Yukitoshi Izumi
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

3.  Long-term depression of NMDA receptor-mediated synaptic transmission is dependent on activation of metabotropic glutamate receptors and is altered to long-term potentiation by low intracellular calcium buffering.

Authors:  Sarah C Harney; Michael Rowan; Roger Anwyl
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

4.  Co-induction of long-term potentiation and long-term depression at a central synapse in the leech.

Authors:  Brian D Burrell; Qin Li
Journal:  Neurobiol Learn Mem       Date:  2008-01-07       Impact factor: 2.877

5.  CNQX and AMPA inhibit electrical synaptic transmission: a potential interaction between electrical and glutamatergic synapses.

Authors:  Qin Li; Brian D Burrell
Journal:  Brain Res       Date:  2008-06-20       Impact factor: 3.252

6.  Differential induction of bidirectional long-term changes in neurotransmitter release by frequency-coded patterns at the cerebellar input.

Authors:  Anna D'Errico; Francesca Prestori; Egidio D'Angelo
Journal:  J Physiol       Date:  2009-12-15       Impact factor: 5.182

7.  Associative, bidirectional changes in neural signaling utilizing NMDA receptor- and endocannabinoid-dependent mechanisms.

Authors:  Qin Li; Brian D Burrell
Journal:  Learn Mem       Date:  2011-08-15       Impact factor: 2.460

8.  Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.

Authors:  Jing Du; Rodrigo Machado-Vieira; Sungho Maeng; Keri Martinowich; Husseini K Manji; Carlos A Zarate
Journal:  Drug Discov Today Ther Strateg       Date:  2006

9.  A Critical Role for Sorting Nexin 1 in the Trafficking of Metabotropic Glutamate Receptors.

Authors:  Rohan Sharma; Ravinder Gulia; Samarjit Bhattacharyya
Journal:  J Neurosci       Date:  2018-08-24       Impact factor: 6.167

Review 10.  Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.

Authors:  Clare M Gladding; Stephen M Fitzjohn; Elek Molnár
Journal:  Pharmacol Rev       Date:  2009-11-19       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.